Latest News for: macula

Edit

Nanoscope Therapeutics Post-Hoc Clinical Analyses to be Presented at 2026 Macula Society Annual Meeting

The Facts 24 Feb 2026
Dr. Christine N. Kay to Present Multivariant Analysis of 3-Year RESTORE and REMAIN Data, Identifying Patient and Disease Characteristics Associated with Best Outcomes in Retinitis Pigmentosa Patients Following MCO-010 Optogenetic Gene Therapy ....
Edit

Ocular Therapeutix™ to Present Detailed SOL-1 Data at the 49th Macula Society Annual Meeting and ...

Nasdaq Globe Newswire 23 Feb 2026
Ocular to present detailed SOL-1 data at the 49th Macula Society Annual Meeting on Friday, February 27, 2026, starting at 1.00 PM PT (4.00 PM ET) ... .
Edit

Apellis Announces Eight Oral Presentations at the 49th Macula Society Annual Meeting

Nasdaq Globe Newswire 19 Feb 2026
APLS) today announced that eight abstracts were ...
Edit

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting

Nasdaq Globe Newswire 28 Jan 2026
... of the Macula Society, taking place February 25-28 in San Diego, California.
Edit

Kalaris to Present Phase 1 Clinical Data for TH103 at the Macula Society Annual Meeting (Kalaris Therapeutics Inc)

Public Technologies 28 Jan 2026
... diseases, today announced that clinical data from its Phase 1 study of TH103 will be presented at the 49th Annual Meeting of the Macula Society, taking place February 25-28 in San Diego, California.
  • 1

Article Search

tools
×
×
×
×